НовостиBenzingaBarclays Maintains Overweight on Omada Health, Lowers Price Target to $24 Barclays Maintains Overweight on Omada Health, Lowers Price Target to $24 Benzinga 2026.10.28 15:48 (GMT+0) Открыть на Benzinga Другие новости